免疫性血小板减少症患者骨髓中的血小板自身抗体
研究改良血小板糖蛋白特异性检测法,检测18例免疫性血小板减少症(ITP)、3例非免疫性血小板减少症和6例健康供者骨髓穿刺液中的游离或细胞结合血小板自身抗体。18例ITP中10例(56%)骨髓检出自身抗体,其中5例仅骨髓阳性;外周血仅6例(33%)阳性。骨髓检测使自身抗体诊断ITP的灵敏度从60%升至72%。
要点
- 18例ITP中10例(56%)骨髓可检出自身抗体,5例(50%)仅骨髓阳性。
- 外周血自身抗体阳性仅6/18例(33%),其中5例(83%)骨髓亦阳性。
- 非免疫性血小板减少症和健康供者骨髓未检出自身抗体。
核心结论
- 部分ITP患者的血小板自身抗体局限于骨髓,可能为特定ITP亚群的特征。
研究设计与样本
- 改良血小板糖蛋白特异性检测法,检测ITP患者(n=18)、非免疫性血小板减少症患者(n=3)和健康供者(n=6)骨髓穿刺液中的游离血小板自身抗体或与骨髓细胞结合的血小板自身抗体。
主要发现
- 18例ITP中10例(56%)骨髓检出自身抗体,其中5例(50%)仅骨髓阳性,5例(50%)骨髓和外周血均阳性。
- 18例ITP中6例(33%)外周血检出自身抗体,其中5例(83%)骨髓亦阳性。
- 非免疫性血小板减少症患者和健康供者骨髓均未检出自身抗体;非免疫性血小板减少症3例中1例(33%)外周血可检出自身抗体。
- 血小板自身抗体诊断ITP的灵敏度从外周血检测的60%升至外周血联合骨髓检测的72%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoantibodies cause platelet destruction in patients with immune thrombocytopenia (ITP); yet only 50% to 60% of patients have detectable platelet autoantibodies in peripheral blood. We hypothesized that in some ITP patients, platelet autoantibodies are sequestered in the bone marrow where pathological immune reactions target megakaryocytes or newly formed platelets. In this study, we modified the platelet glycoprotein-specific assay to test bone marrow aspiration samples for free platelet autoantibodies or antibodies bound to bone marrow cells in aspirate fluid from patients with ITP (n = 18), patients with nonimmune thrombocytopenia (n = 3), and healthy donors (n = 6). We found that 10 (56%) of 18 patients with ITP had autoantibodies in the bone marrow, including 5 (50%) of 10 with autoantibodies in bone marrow only, and 5 (50%) of 10 with autoantibodies in bone marrow and peripheral blood. In comparison, 6 (33%) of 18 ITP patients had autoantibodies in peripheral blood, most of whom (5 [83%] of 6) also had autoantibodies in bone marrow. Bone marrow autoantibodies were not detected in patients with nonimmune thrombocytopenia or healthy donors; however, peripheral blood autoantibodies were detectable in 1 (33%) of 3 patients with nonimmune thrombocytopenia. The sensitivity of platelet autoantibodies for the diagnosis of ITP increased from 60% (peripheral blood testing) to 72% (peripheral blood and bone marrow testing). Immune reactions limited to the bone marrow may be characteristic of certain subsets of ITP patients.
引用
- Shrestha S, Nazy I, Smith JW, et al. Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia. Blood Adv. 2020. PMID: 32603421. doi:10.1182/bloodadvances.2020001846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。